| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |